SVB Securities

What SVB Securities does

SVB Securities, operating as Leerink Partners, is a Boston-headquartered, healthcare-exclusive investment bank founded in 1995, employing 251–500 staff and operating under the legacy svbleerink.com web domain. The firm provides four service lines: investment banking advisory (M&A and capital markets transactions), equity research, sales & trading, and corporate access, alongside proprietary platforms MEDACorp (an expert network connecting corporate clients with healthcare specialists) and the Center For Pharmacoeconomics. The client base spans biopharma (from growth-stage biotechs to large-cap pharmaceutical companies), digital health and health technology, healthcare services (payers and providers), MedTech, and tools & diagnostics, with named mandates including biopharma issuers (uniQure, Ligand, MoonLake), specialty finance (FS KKR Capital Corp.), and the nation's largest payers and providers.

The firm's revenue model is professional services-based: transaction fees on underwriting and bookrunning roles in capital markets (public offerings, follow-ons, convertible notes), advisory fees on M&A engagements (85+ transactions completed to date), recurring institutional revenue from equity research distribution, and corporate access fees. Pricing is quote-based and engagement-specific; no public fee schedule exists. Senior bankers lead engagements end-to-end from deal origination through closing. The firm's go-to-market relies on enterprise field sales via senior-banker-led relationships with institutional investors and corporate healthcare clients, augmented by top-of-funnel demand generation through research publications, podcasts, newsletters, and professional network presence on LinkedIn.

Scale of the franchise, as of May 31, 2026, includes 1,500+ lifetime transactions, $220B+ in lifetime capital raised for clients, and 85+ M&A advisory transactions, with recent June 2026 bookrunner mandates across follow-on equity and convertible debt offerings. The firm was formerly part of SVB Financial Group prior to the 2023 SVB collapse and continues to operate under the Leerink Partners trade name with the svbleerink.com domain as a residual artifact.

Name

SVB Securities

Website

https://svbleerink.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

251–500 employees

Short description

SVB Securities (operating as Leerink Partners) is a Boston-based, healthcare-exclusive boutique investment bank founded in 1995, providing M&A advisory, capital markets underwriting, equity research, and sales & trading services to biopharma, digital health, healthcare services, MedTech, and tools & diagnostics clients across growth-stage to large-cap companies.

Ownership category

akta.pro rank

Product category

Healthcare Investment Banking

NAICS

Investment Banking and Securities Intermediation (52315), Investment Banking and Securities Intermediation (523150), Securities and Commodity Contracts Intermediation and Brokerage (5231)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)

akta.pro primary industry

M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA)

akta.pro secondary industries

Buy-Side M&A Advisory (FSAEAGAB), Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC), Corporate Finance & Capital Advisory (BPAHADAB), Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE)

Keywords

• Healthcare investment banking
• Equity research services
• Capital markets advisory
• Mergers and acquisitions advisory
• Sales and trading

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Investment Banking Advisory: M&A advisory, capital markets transactions including public offerings, follow-ons, convertible notes. Senior bankers lead engagements from origination to closing with 1,500+ transactions completed and $220B+ capital raised.
2. Equity Research: Deep healthcare coverage providing industry insights to institutional investors. Generates research-based revenue through institutional client relationships.
3. Sales & Trading: Highly specialized connectivity to institutional investors for trading and execution services.
4. Corporate Access: Exclusive relationship-building opportunities connecting companies with institutional investors.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

SVB Securities is a specialist healthcare investment bank providing M&A advisory, capital markets transaction execution (public offerings, follow-ons, convertible notes), equity research, sales & trading, and corporate access services exclusively to healthcare companies and institutional investors. The firm has completed 1,500+ transactions and raised $220B+ for healthcare clients as of May 31, 2026, with senior bankers leading engagements from origination to closing across biopharma, digital health, healthcare services, MedTech, and tools & diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

• Investment Banking Advisory M&A advisory and strategic financial advice services for healthcare companies. Includes buy-side and sell-side M&A representation and has executed 85+ M&A advisory transactions.
• Capital Markets Capital markets transaction execution including public offerings, follow-on offerings, and Rule 144A convertible senior notes offerings for healthcare companies. Recent transactions include $700M Follow-On, $200M Lead-Left Bookrunner, $225M Bookrunner, and $625M Rule 144A Convertible Senior Notes Offering.
• Equity Research

Quantifiable outcome

• 1,500+ transactions completed as of May 31, 2026
• +2 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

One partnership is on record.

• FINRA/SIPCminorOthersRegulatory memberships - Member of FINRA and SIPC

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Jefferies Healthcare Group: Jefferies operates one of the largest dedicated healthcare investment banking franchises on Wall Street, providing M&A advisory and capital markets services to biopharma, MedTech, and healthcare services clients — directly competing with SVB Securities for healthcare mandates.
• Piper Sandler Healthcare: Piper Sandler runs a sizable healthcare investment banking group focused on biopharma, diagnostics, and MedTech, often serving as lead-left bookrunner on mid-cap healthcare follow-ons and IPOs — a direct competitor in the same mid-to-large cap healthcare segment.
• Guggenheim Securities Healthcare: Guggenheim Securities operates a dedicated healthcare investment banking practice covering biopharma, MedTech, and healthcare services, frequently competing as joint bookrunner on convertible and equity offerings for healthcare issuers.
• Cantor Fitzgerald Healthcare: Cantor Fitzgerald has built a healthcare-focused investment banking franchise covering biopharma, specialty pharma, and healthcare services — competing directly with SVB Securities for mid-cap healthcare advisory and capital markets mandates.
• TD Cowen Healthcare: TD Cowen operates a healthcare investment banking franchise offering M&A advisory and capital markets services to biopharma, diagnostics, and MedTech clients — a direct competitor in healthcare equity capital markets and advisory.

Broad incumbents

• Houlihan Lokey Healthcare: Houlihan Lokey is a large, diversified investment bank with a growing healthcare vertical — broader than SVB Securities but competes directly on healthcare M&A advisory mandates, particularly in the mid-cap segment.
• Centerview Partners: Centerview is a leading independent advisory firm with significant healthcare M&A activity serving large-cap healthcare clients — a higher-end M&A advisory competitor that overlaps with SVB Securities on biopharma and healthcare services deals.
• Lazard Healthcare: Lazard operates a global healthcare practice covering biopharma, MedTech, and healthcare services, often advising on the largest healthcare M&A transactions — a broader incumbent that overlaps with SVB Securities on premium healthcare mandates.
• Goldman Sachs Healthcare: Goldman Sachs has a top-tier global healthcare investment banking franchise across advisory, equity capital markets, and debt capital markets — a bulge bracket incumbent that frequently competes with SVB Securities on lead-left roles for large healthcare transactions.
• Morgan Stanley Healthcare: Morgan Stanley maintains a leading global healthcare investment banking franchise across M&A, ECM, and DCM — a bulge bracket incumbent that frequently co-manages or competes directly with SVB Securities on healthcare transactions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments4 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SVB Securities